Latest Features & Opinion

Live Coverage of AAIC 2018

Follow Neurology Advisor's coverage of the 2018 Alzheimer's Association International Conference live from Chicago.

Time Matters In MS: Expert Q&A

In April 2018, the American Academy of Neurology released updated guidelines for the treatment of multiple sclerosis (MS). The new recommendations are based on a panel review of 20 Cochrane reviews and 73 full-text articles pertaining to starting, switching, and stopping disease-modifying treatment in patients with clinically isolated syndrome, relapsing-remitting MS, and progressive forms of MS.

Emerging Innovations in Parkinson Disease Treatment

Surgical interventions for Parkinson disease are experiencing a swell in innovation, thanks in part to the entry of two additional medical device companies into a field previously dominated by one company.

Live Coverage of AHS 2018

Follow Neurology Advisor for live updates from the 2018 American Headache Society Annual Meeting from San Francisco, California.

Addressing Migraine That Mimics Stroke

Neurology Advisor spoke with Dr Peter McAllister about how to best discern migraine with aura from stroke.

Diagnosing, Treating CNS Fungal Infections

While immunocompromised patients are the most susceptible to CNS fungal infections, they can also occur in immunocompetent patients undergoing invasive procedures such as neurosurgery and in patients exposed to contaminated devices or drugs.

The Evolution of NEDA

Each component of NEDA has limitations — for example, measures of brain atrophy may be confounded by various factors, and the correlation between short-term measures of EDSS progression and long-term disability outcomes is unclear.

Managing Neurological Manifestations of Sjogren Syndrome

Experts discuss the symptoms and prevalence of neurological manifestations in Sjogren syndrome.

The Consequences of Compensation in Autism

Although compensating for their difficulties may help people with ASD connect with others, get jobs, and successfully navigate social situations, accumulating research suggests it can also lead to exhaustion, burnout, anxiety, and depression.
Navigating the Waters of Medical Malpractice and Defensive Medicine

Navigating the Waters of Medical Malpractice and Defensive Medicine

Malpractice liability reform would best be analyzed on a specialty-by-specialty basis.

FOR YOUR PRACTICE

Practice Management

The Little Guy vs Big Data: Is ICD-10 Coding Still Valuable in Health Care?

The Little Guy vs Big Data: Is ICD-10 Coding Still Valuable in Health Care?

While ICD-10-CM may be an improvement on an old process, big data is the revolution that has the potential to change health care forever.

Drug Lookup

Search our drug information database which contains an extensive list of neurologic drugs.

Browse drugs by:

Brand Generic Disease

Latest in Autism Spectrum Disorder

Prenatal Tdap Vaccination Not Linked to Autism Risk

Prenatal tetanus, diphtheria, acellular pertussis vaccination is not associated with increased risk of autism spectrum disorder in offspring.

Increased Risk of Autism, ADHD May Be Linked to Hypertensive Disorders of Pregnancy

A literature review was conducted to assess the association between hypertensive disorders of pregnancy and neurodevelopmental disorders in offspring.

Some Common Allergies Linked to Odds of Autism in Children

Common allergic conditions, especially food allergy, are associated with autism spectrum disorder in children.

Latest in Neuromuscular Disorders

OCD in Duchenne Muscular Dystrophy Features Distinct Phenotype, Associated Symptoms

Investigators aim to facilitate early recognition and consideration for patients with Duchenne muscular dystrophy and internalizing psychiatric symptoms.

Understanding ICU-Acquired Neuromuscular Dysfunction: Triggers, Risk Factors, and Treatments

ICU-acquired weakness syndromes manifest themselves in a range of ways among patients — as a spectrum of disease rather than in specific form.

FDA Lifts Clinical Hold on Trial for Duchenne Muscular Dystrophy Treatment

SGT-001 is a novel adeno-associated viral vector mediated gene transfer that could potentially address the underlying genetic cause of DMD, mutations in the dystrophin gene.

Sign Up for Free e-newsletters



CME Focus